Alana Gouveia is a scientist in the Liquid Formulation R&D lab at MilliporeSigma in Darmstadt, working on highly concentrated protein formulations (HCPF). She is the global lead for the Feasibility Assessment Service offering. As such, she is supporting customers in the technology evaluation of the Viscosity Reduction Platform (VRP). Alana’s role is highly customer-oriented, and she has a profound experience working on highly concentrated antibody formulations. Alana holds a master’s degree from the Technical University of Darmstadt, where she focused on highly viscous protein formulation during her thesis.